英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
marinus查看　marinus　在百度字典中的解释百度英翻中〔查看〕
marinus查看　marinus　在Google字典中的解释Google英翻中〔查看〕
marinus查看　marinus　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Home - Marinus Pharmaceuticals
    Marinus Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, offering a new mechanism of action with demonstrated safety and convenient dosing for patients affected by epilepsy and CNS disorders
  • About Marinus - Marinus Pharmaceuticals
    Marinus is committed to improving the lives of patients with seizure disorders through the development of innovative treatment options and by closely collaborating with patients, caregivers and healthcare professionals
  • Marinus Pharmaceuticals, Inc. - Immedica to Acquire Biopharmaceutical . . .
    Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc (Nasdaq: MRNS), a pharmaceutical company committed to improving the lives of patients with seizure disorders, today announced that they have entered into an agreement and plan of merger under which Immedica has agreed to acquire Marinus, by
  • Pipeline - Marinus Pharmaceuticals
    Pipeline Clinical Trial Information Ganaxolone is being developed in intravenous (IV) and oral formulations intended to maximize therapeutic reach to patient populations in both acute and chronic care settings Information about Marinus' clinical trials can be found on ClinicalTrials gov
  • Marinus Pharmaceuticals Provides Business Update and Reports Third . . .
    Marinus is a commercial-stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders The Company’s product, ZTALMY ® (ganaxolone) oral suspension CV, is an FDA-approved prescription medication introduced in the U S in 2022
  • Our Medicine - Marinus Pharmaceuticals
    Marinus Pharmaceuticals About About Us; Support Sponsorship; Medicine; Science Pipeline Our Science; Pipeline; Medical Affairs Marinus Posters; Managed Access Programs; Investigator Initiated Studies; Focus Areas Status Epilepticus (SE) BARDA Agreement; Tuberous Sclerosis Complex (TSC) CDKL5 Deficiency Disorder (CDD) Patients Telehealth
  • Leadership - Marinus Pharmaceuticals
    Meet the Marinus Team Marinus’ management team is committed to developing innovative treatment options for seizures disorders in both the hospital and home setting
  • Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC . . .
    Marinus is a commercial-stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders The Company’s product, ZTALMY ® (ganaxolone) oral suspension CV, is an FDA-approved prescription medication introduced in the U S in 2022
  • Marinus Pharmaceuticals, Inc. - Marinus Pharmaceuticals Announces FDA . . .
    Marinus is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders Ganaxolone is a neuroactive steroid GABA A receptor modulator that acts on a well-characterized target in the brain known to have anti-seizure effects
  • Join Our Team - Marinus Pharmaceuticals
    Important information about Marinus’ Early Talent Program For rising undergraduate Juniors and higher—must be currently enrolled in school; Internship cycle: 10-12 week summer program, late May-early September; All internships are up to 40 hours per week and all positions are paid; Additionally, Marinus’ internships offer: Competitive





中文字典-英文字典  2005-2009